Ecolab Inc. (ECL) M&A Name March 23, 2026 8:00 AM EDT
Firm Contributors
Andy Hedberg – Director of Investor Relations
Christophe Beck – CEO & Chairman of the Board
Scott Kirkland – Chief Monetary Officer
Convention Name Contributors
Timothy Mulrooney – William Blair & Firm L.L.C., Analysis Division
John Ronan Kennedy – Barclays Financial institution PLC, Analysis Division
Ashish Sabadra – RBC Capital Markets, Analysis Division
John McNulty – BMO Capital Markets Fairness Analysis
Seth Weber – BNP Paribas, Analysis Division
Andrew J. Wittmann – Robert W. Baird & Co. Included, Analysis Division
Steven Haynes – Morgan Stanley, Analysis Division
Patrick Cunningham – Citigroup Inc., Analysis Division
David Begleiter – Deutsche Financial institution AG, Analysis Division
Shlomo Rosenbaum – Stifel, Nicolaus & Firm, Included, Analysis Division
Edlain Rodriguez – Mizuho Securities USA LLC, Analysis Division
Jason Haas – Wells Fargo Securities, LLC, Analysis Division
Presentation
Operator
Greetings. Welcome to Ecolab’s acquisition of CoolIT Methods Convention Name. [Operator Instructions] As a reminder, this convention is being recorded. Right now, it’s now my pleasure to introduce your host, Andy Hedberg, Vice President, Investor Relations. Thanks, Andy. It’s possible you’ll now start.
Andy Hedberg
Director of Investor Relations
Thanks. Good day, everybody, and welcome to Ecolab’s convention name to debate our introduced acquisition of CoolIT Methods. With me immediately is Christophe Beck, Ecolab’s Chairman and CEO; and Scott Kirkland, our CFO.
Right now’s presentation deck is out there on our Investor Relations web site. You’ll be able to entry it now and observe alongside all through the decision. Please take a second to learn the cautionary statements in these supplies, which state that this teleconference and the related supplemental supplies embody estimates of future efficiency. These are forward-looking statements, and precise outcomes may differ materially from these projected. Components that might trigger precise outcomes to vary are described within the Danger Components part in our most up-to-date Type 10-Ok and in our posted supplies.
